z-logo
open-access-imgOpen Access
SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects
Author(s) -
Sheera R. Rosenbaum,
Manoela Tiago,
Signe Caksa,
Claudia Capparelli,
Timothy J. Purwin,
Gaurav Kumar,
McKenna Q. Glasheen,
Danielle Pomante,
Daniel Kotas,
Inna Chervoneva,
Andrew E. Aplin
Publication year - 2021
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2021.110085
Subject(s) - immune system , melanoma , sox10 , cancer research , biology , immunology , immune checkpoint , microbiology and biotechnology , immunotherapy , neural crest , embryo

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom